Jason Ehrlich - May 12, 2021 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role
Chief Medical Officer and Chief Development Officer
Signature
/s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich
Stock symbol
KOD
Transactions as of
May 12, 2021
Transactions value $
$74,240
Form type
4
Date filed
5/14/2021, 05:22 PM
Next filing
May 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KOD Common Stock Options Exercise $55.3K +5.38K +8.56% $10.29 68.2K May 12, 2021 Direct
transaction KOD Common Stock Options Exercise $18.9K +1.89K +2.77% $10.00 70.1K May 12, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KOD Stock Option (Right to Buy) Options Exercise $0 -5.38K -2.04% $0.00 259K May 12, 2021 Common Stock 5.38K $10.29 Direct F1
transaction KOD Stock Option (Right to Buy) Options Exercise $0 -1.89K -3.33% $0.00 54.8K May 12, 2021 Common Stock 1.89K $10.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
F2 One-sixtieth of the shares subject to the option vested on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter.

Remarks:

Chief Medical Officer and Chief Development Officer